Latest News and Press Releases
Want to stay updated on the latest news?
-
Update on the Share Buyback Program and the Liquidity Agreement Period from 16 July 2026 to 22 July 2026 Share Buyback ProgramOn 26 February 2026, Bekaert announced the start of the next tranche of...
-
Q3 2025–2026 revenue: -18.7%A quarter affected by a persistently weak agricultural cycle, with contrasting dynamics across business activitiesQ3 sales(April 2026–June 2026)) 2024–20252025–2026Change...
-
Company Announcement No. 1171 DSV A/S hereby provides notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in DSV A/S made by a manager. ...
-
UAB Urbo bankas (hereinafter – the Bank), juridinio asmens kodas 112027077, adresas: Konstitucijos pr. 18B, Vilnius. The Bank hereby informs that, following the receipt of permission from the...
-
Company announcement No. 44/2026 24 July 2026 Major shareholder announcement Netcompany Group A/S ("Netcompany") hereby announces the following notification received pursuant to section 38, 39,...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS ...
-
AS Tallinna Vesi invites its shareholders, investors, analysts, and other stakeholders to join its investor conference webinar, introducing the results for the 2nd quarter and 6 months of 2026. The...
-
LEI: 213800NNT42FFIZB1T09 24 July 2026 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital for...
-
Following the announcement of changes to Inbank's operating model on 19 June 2026, the Inbank Supervisory Board has resolved to appoint Marten Meikop as Chief Technology Officer (CTO) and member of...
-
Sanofi today announced discontinuation of clinical development of amlitelimab, an OX40-ligand monoclonal antibody, in moderate-to-severe atopic dermatitis.